glp -1 agonist GLP-1 receptor agonists show promise in treating substance use disorders Glucagon-like peptide-1 receptor: mechanisms and
Description
Supports gut lining integrity
Obesity and Type 2 diabetes represent global health challenges, and there is an unmet need for long-lasting and effective pharmacotherapies
Youve likely heard about glucagon-like peptide-1 agonists commonly referred to as GLP-1 medications, and more widely recognized through pharmaceutical brand names like Ozempic and Mounjaro.
See how GLP-1s are reshaping diabetes & obesity care.
Yale Medicine experts explain who qualifies, who can prescribe, and what to expect.
Within the first seven days, youll feel it working!*
